Journal of Labelled Compounds and Radiopharmaceuticals

EDITOR-IN-CHIEF
K M W Lawrie
GlaxoSmithKline
Isotope Chemistry
Medicines Research Centre
Stevenage
Herts, SG1 2NY, UK
E-mail: ken.w.lawrie@gsk.com

EDITORS

LABELLED COMPOUNDS EDITOR FOR NORTH AMERICA
W J Wheeler
12030 Emerald Bluff
Indianapolis,
IN 46236, USA
E-mail: isotopicsolutions@comcast.net

Labelled Compounds Editor for Europe
T Moenius
Isotope Laboratory
Novartis
Huenigerstrasse WSJ507.95
CH-4002, Basel
Switzerland
E-mail: thomas.moenius@novartis.com

RADIOPHARMACEUTICALS EDITOR
B Långström
Uppsala University
Institute of Chemistry/PET Centre
S-751 85 Uppsala, Sweden
E-mail: bengt.langstrom@ge.com

RADIOPHARMACEUTICALS EDITOR
FOR NORTH AMERICA
R F Dannals
Division of Nuclear Medicine
The Johns Hopkins Medicine
600 North Wolfe Street
Nelson Bl-127
Baltimore, Maryland 21287-0816, USA
E-mail: robert_dannals@tracer.nm.jhu.edu

RADIOPHARMACEUTICALS EDITOR
FOR ASIA, AUSTRALIA AND NEW ZEALAND
M Kassiou
Brain and Mind Research Institute
School of Chemistry, Building F11
University of Sydney
NSW 2050, Australia
E-mail: michael.kassiou@sydney.edu.au

REVIEW EDITOR
F. Aigbirhio
Wolfson Brain Imaging Centre
University of Cambridge
Addenbrooke’s Hospital ,
Cambridge, CB2 2QQ, UK
E-mail: fia20@wbic.cam.ac.uk

ADVISORY BOARD

J Allen
Sanofi-Aventis
Chilly Mazarin Cedex, France

J Atzrodt
Sanofi-Aventis
Frankfurt, Germany

E Buncel
Queen's University,
Ontario, Canada

M Chappelle
Quotient Bioresearch,
Cardiff, Wales, UK

D Y Chi
Sogang University,
Seoul, Korea

H H Coenen
Institute für Nuclearchemie,
Jülich, Germany

F Dollé
CEA, Institut d'imagerie biomédicale,
CEA Orsay, France

C N Filer
NEN Life Science Products, Inc.
Boston, USA

Y. Fujibayashi
National Institute of Radiological Sciences
Chiba, Japan

D Hesk
Westfield,
NJ, USA

G W Kabalka
University of Tennessee
Knoxville, USA

J A Katzenellenbogen
University of Illinois at Urbana-Champaign
Urbana, USA

 H F Kung
University of Pennsylvania School of Medicine
Philadelphia, USA

 W J S Lockley
University of Surrey
Guildford, Surrey, UK

M H Marx
EaglePicher Pharmaceutical Services
Lenexa, Kansas, USA

B Maxwell
Bristol-Myers Squibb
Princeton, NJ, USA

N F Myasoedov
Institute of Molecular Genetics
Russian Academy of Sciences
Moscow, Russia

V W Pike
Molecular Imaging Branch
National Institute of Mental Health,
Bethesda, MD, USA

U Pleiss
Bayer Healthcare AG,
Wuppertal, Germany

H Saji
Kyoto University,
Kyoto, Japan

R Salter
Johnson & Johnson,
Raritan, NJ 08869, USA

D Saunders
IsoSciences LLC,
King of Prussia, USA

S Stone-Elander
Clinical Neurosciences Division
Karolinska Pharmacy,
Stockholm, Sweden

A B Susan
International Isotope Clearing House Inc (IICH Inc)
Kansas, USA

M L Thakur
Thomas Jefferson University Hospital
Philadelphia, USA

M Venkatesh
Homi Bhabha National Institute
Mumbai, India

R Voges
Novartis Pharma AG
Basel, Switzerland

C L Willis
University of Bristol
Bristol, UK

A Windhorst
VU University Medical Center
Amsterdam, The Netherlands

M R Zalutsky
Duke University Medical Center
Durham, USA

X Zhang
Beijing Normal University
Beijing, China